Table 2.
Neurological associations, cerebrospinal fluid analysis, and radiological features (n=18)
| Variable | n (%) |
|---|---|
| Neurological syndromes-associated with opsoclonus | |
| Myoclonus | 9 (50) |
| Cerebellar dysfunction | 8 (44) |
| Extrapyramidal syndrome | 6 (33) |
| Concomitant meningitis/meningoencephalitis | 3 (17) |
| CSF analysis | |
| Meningitis group (n=3) | |
| Mean CSF WBC (cell/cumm) | 55±12.2 |
| Mean CSF protein (mg/dl) | 69.3±12.2 |
| Mean CSF glucose (mg/dl) | 50±8 |
| Nonmeningitis group (n=11) | |
| Mean CSF WBC (cell/cumm) | 9±2.7 |
| Mean CSF protein (mg/dl) | 118.5±53.9 |
| Mean CSF glucose (mg/dl) | 97±13 |
| MRI brain (n=12) | |
| Cerebellitis | 3 (25) |
| Brain stem enhancement | 0 |
| Normal | 9 (75) |
| Outcome | |
| Duration of hospital stay (mean±SD days) | 11±7.8 |
| Case fatality rate | 1 (6) |
| Resolution of nonneurological illnesses at discharge | 16 (94) |
| Persistence of neurological syndrome at discharge | 17 (100) |
SD=Standard deviation, WBC=White blood cell, CSF=Cerebrospinal fluid